Breast cancer: further metabolic-endocrine risk markers?
1997
Breast Cancer and Risk Markers
publication
Author Information
Author(s): BA Stoll
Primary Institution: The Department of Oncology, St Thomas' Hospital, London SE1 7EH, UK
Hypothesis
Increased oestrogen receptor expression in normal mammary epithelium may be a risk marker for the development of breast cancer.
Conclusion
The study suggests that the combined effect of oestradiol and IGF1 may stimulate proliferation in normal mammary epithelium and increase breast cancer risk.
Supporting Evidence
- Increased oestrogen receptor expression may indicate a higher risk of breast cancer.
- Insulin-like growth factor 1 (IGF1) can promote the growth of breast cancer cells.
- Hyperinsulinaemia is associated with higher IGF1 levels and may be a risk marker for breast cancer.
Takeaway
This study looks at how certain hormones and proteins might increase the risk of breast cancer by making breast cells grow more. If we understand these markers better, we can find ways to help women at risk.
Want to read the original?
Access the complete publication on the publisher's website